Patches wont replace prescriptions
10.1164/rccm.201303-0427OC Am J Respir Crit Care Med
In these populations, GLP-1 medications may: Suppress appetite in ways that destabilize recovery Mask symptoms without addressing underlying drivers Increase psychological distress related to food, weight, or control Any consideration of GLP-1 use should involve careful medical oversight, psychological evaluation, and ongoing monitoring
Monoamine Oxidase Inhibitors (MAOIs) The concomitant use of opioids and MAOIs, such as phenelzine, tranylcypromine, linezolid, may manifest as serotonin syndrome or opioid toxicity (e.g., respiratory depression, coma) [see WARNINGS]
This injection forces rapid surfactant production so the lungs can expand easily at birth
Benefits are still being researched, so claims stay measured